L. B. Grabenhenrich, S. D?-olle, A. Moneret-vautrin, A. K?-ohli, L. Lange et al., Anaphylaxis in children and adolescents: the European anaphylaxis registry, J Allergy Clin Immunol, vol.137, pp.1128-1165, 2016.

A. Jennings, E. Duggan, I. J. Perry, and J. O. Hourihane, Epidemiology of allergic reactions to hymenoptera stings in Irish school children, Pediatr Allergy Immunol, vol.21, pp.1166-70, 2010.

G. J. Sturm, E. M. Varga, G. Roberts, H. Mosbech, . Bil-o-mb et al., EAACI guidelines on allergen immunotherapy: hymenoptera venom allergy, Allergy, vol.73, pp.744-64, 2018.

C. Galera, N. Soohun, N. Zankar, S. Caimmi, C. Gallen et al., Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab, J Investig Allergol Clin Immunol, vol.19, pp.225-234, 2009.

E. Stretz, E. M. Oppel, . Hc, R. Chatelain, S. Mastnik et al., Overcoming severe adverse reactions to venom immunotherapy using anti-IgE antibodies in combination with a high maintenance dose, Clin Exp Allergy, vol.47, pp.1631-1640, 2017.

L. Ricciardi, Omalizumab: a useful tool for inducing tolerance to bee venom immunotherapy, Int J Immunopathol Pharmacol, vol.29, pp.726-734, 2016.

B. Ruiz, P. Serrano, and C. Moreno, IgE-Api m 4 is useful for identifying a particular phenotype of bee venom allergy, J Investig Allergol Clin Immunol, vol.26, pp.355-61, 2016.

V. Soriano-gomis, G. Delgado, P. , N. Hernandez, and E. , Failure of omalizumab treatment after recurrent systemic reactions to bee-venom immunotherapy, J Investig Allergol Clin Immunol, vol.18, pp.225-231, 2008.

I. Y?lmaz, S. N. Bahçecioglu, and T. Murat, Combination of omalizumab and bee venom immunotherapy: does it work?, Asia Pac Allergy, vol.8, p.2, 2018.

C. Lin, I. T. Lee, V. Sampath, C. Dinakar, R. H. Dekruyff et al., Combining anti-IgE with oral immunotherapy, Pediatr Allergy Immunol, vol.28, pp.619-646, 2017.

P. A. Frischmeyer-guerrerio, M. Masilamani, W. Gu, E. Brittain, R. Wood et al., Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy, J Allergy Clin Immunol, vol.140, pp.1043-53, 2017.

M. Nittner-marszalska, E. Cichocka-jarosz, T. Ma?aczy-nska, B. Kraluk, M. Rosiekbiegus et al., Safety of ultrarush venom immunotherapy: comparison between children and adults, J Investig Allergol Clin Immunol, vol.26, pp.40-47, 2016.